Back
Halozyme Therapeutics Vs. Lexicon Pharmaceuticals Industry Stock Comparison
Buy
53
HALO
Halozyme Therapeutics
Last Price:
47.79
Seasonality Move:
17.34%
Sell
26
LXRX
Lexicon Pharmaceuticals
Last Price:
0.81
Seasonality Move:
18.61%
Buy
53
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $47.79. The Score for HALO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- HALO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Lexicon Pharmaceuticals (LXRX)
is a Sell
Is Lexicon Pharmaceuticals a Buy, Sell or Hold?
- The current Lexicon Pharmaceuticals [LXRX] share price is $0.82. The Score for LXRX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- LXRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $47.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.
LXRX Stock Price Chart
What is Lexicon Pharmaceuticals's stock price today?
-
The Lexicon Pharmaceuticals share price today is $0.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LXRX is experiencing slight selling pressure.
HALO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.26 | Sell |
Relative Strength Index (14 RSI): | 41.07 | Sell |
Chaikin Money Flow: | 837944 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.59 - 58.19) | Sell |
Bollinger Bands (100): | (51.1 - 60.64) | Sell |
LXRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 27.37 | Sell |
Chaikin Money Flow: | 29373 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.87 - 1.71) | Sell |
Bollinger Bands (100): | (1.3 - 2.02) | Sell |
HALO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.13 | Buy |
20-day SMA: | 52.96 | Sell |
50-day SMA: | 54.19 | Sell |
200-day SMA: | 49.33 | Sell |
8-day EMA: | 48.36 | Sell |
20-day EMA: | 50.94 | Sell |
50-day EMA: | 53.37 | Sell |
200-day EMA: | 50.43 | Sell |
LXRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.85 | Sell |
20-day SMA: | 1.14 | Sell |
50-day SMA: | 1.49 | Sell |
200-day SMA: | 1.84 | Sell |
8-day EMA: | 0.89 | Sell |
20-day EMA: | 1.11 | Sell |
50-day EMA: | 1.39 | Sell |
200-day EMA: | 1.69 | Sell |
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.22 per share.
Halozyme Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lexicon Pharmaceuticals Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |